Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1988 Oct;56(10):2615–2622. doi: 10.1128/iai.56.10.2615-2622.1988

Binding characteristics of Escherichia coli adhesins in human urinary bladder.

R Virkola 1, B Westerlund 1, H Holthöfer 1, J Parkkinen 1, M Kekomäki 1, T K Korhonen 1
PMCID: PMC259620  PMID: 2901404

Abstract

We studied domains in the human bladder that acted as receptors for Escherichia coli P, S, type 1, type 1C, and O75X fimbriae or adhesin and domains in the human kidneys that were receptors for E. coli type 1C fimbriae. Binding sites in frozen tissue sections were localized by direct staining with fluorochrome-labeled recombinant strains and by indirect immunofluorescence with the purified adhesins. In the bladder, the P and S fimbriae showed closely similar binding to the epithelial and muscular layers, and the S fimbriae also bound to the connective tissue elements. Type 1 fimbriae bound to vascular walls and to muscle cells, whereas the O75X adhesin bound avidly to connective tissue elements and to some extent to epithelial and muscle cells of the bladder. The type 1C fimbriae bound to distal tubules and collecting ducts of the kidney and to vascular endothelial cells in both the kidney and bladder. The binding of all adhesin types was inhibited by specific receptor analogs or Fab fragments. The results reveal a possible mechanism by which the type 1C fimbriae may help invasion of E. coli in the kidneys but do not support a pathogenetic role for type 1 fimbriae. Similar tissue specificity of P and S fimbriae in the human urinary tract indicates that the presence of binding sites on uroepithelia does not fully explain the virulence properties of P fimbriae in human urinary tract infections.

Full text

PDF
2615

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronson M., Medalia O., Schori L., Mirelman D., Sharon N., Ofek I. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside. J Infect Dis. 1979 Mar;139(3):329–332. doi: 10.1093/infdis/139.3.329. [DOI] [PubMed] [Google Scholar]
  2. Blumenstock E., Jann K. Adhesion of piliated Escherichia coli strains to phagocytes: differences between bacteria with mannose-sensitive pili and those with mannose-resistant pili. Infect Immun. 1982 Jan;35(1):264–269. doi: 10.1128/iai.35.1.264-269.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boyer H. W., Roulland-Dussoix D. A complementation analysis of the restriction and modification of DNA in Escherichia coli. J Mol Biol. 1969 May 14;41(3):459–472. doi: 10.1016/0022-2836(69)90288-5. [DOI] [PubMed] [Google Scholar]
  4. Breimer M. E., Hansson G. C., Leffler H. The specific glycosphingolipid composition of human ureteral epithelial cells. J Biochem. 1985 Nov;98(5):1169–1180. doi: 10.1093/oxfordjournals.jbchem.a135383. [DOI] [PubMed] [Google Scholar]
  5. Edén C. S., Hanson L. A., Jodal U., Lindberg U., Akerlund A. S. Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet. 1976 Sep 4;1(7984):490–492. [PubMed] [Google Scholar]
  6. Ekblom P., Miettinen A., Virtanen I., Wahlström T., Dawnay A., Saxén L. In vitro segregation of the metanephric nephron. Dev Biol. 1981 May;84(1):88–95. doi: 10.1016/0012-1606(81)90373-0. [DOI] [PubMed] [Google Scholar]
  7. Goetz M. B., Kuriyama S. M., Silverblatt F. J. Phagolysosome formation by polymorphonuclear neutrophilic leukocytes after ingestion of Escherichia coli that express type 1 pili. J Infect Dis. 1987 Jul;156(1):229–233. doi: 10.1093/infdis/156.1.229. [DOI] [PubMed] [Google Scholar]
  8. Hacker J., Schmidt G., Hughes C., Knapp S., Marget M., Goebel W. Cloning and characterization of genes involved in production of mannose-resistant, neuraminidase-susceptible (X) fimbriae from a uropathogenic O6:K15:H31 Escherichia coli strain. Infect Immun. 1985 Feb;47(2):434–440. doi: 10.1128/iai.47.2.434-440.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hagberg L., Engberg I., Freter R., Lam J., Olling S., Svanborg Edén C. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun. 1983 Apr;40(1):273–283. doi: 10.1128/iai.40.1.273-283.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hagberg L., Hull R., Hull S., Falkow S., Freter R., Svanborg Edén C. Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun. 1983 Apr;40(1):265–272. doi: 10.1128/iai.40.1.265-272.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hagberg L., Jodal U., Korhonen T. K., Lidin-Janson G., Lindberg U., Svanborg Edén C. Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun. 1981 Feb;31(2):564–570. doi: 10.1128/iai.31.2.564-570.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hennigar R. A., Schulte B. A., Spicer S. S. Heterogeneous distribution of glycoconjugates in human kidney tubules. Anat Rec. 1985 Apr;211(4):376–390. doi: 10.1002/ar.1092110403. [DOI] [PubMed] [Google Scholar]
  13. Holthöfer H. Lectin binding sites in kidney. A comparative study of 14 animal species. J Histochem Cytochem. 1983 Apr;31(4):531–537. doi: 10.1177/31.4.6827083. [DOI] [PubMed] [Google Scholar]
  14. Holthöfer H., Virtanen I., Pettersson E., Törnroth T., Alfthan O., Linder E., Miettinen A. Lectins as fluorescence microscopic markers for saccharides in the human kidney. Lab Invest. 1981 Nov;45(5):391–399. [PubMed] [Google Scholar]
  15. Johnson J. R., Roberts P. L., Stamm W. E. P fimbriae and other virulence factors in Escherichia coli urosepsis: association with patients' characteristics. J Infect Dis. 1987 Jul;156(1):225–229. doi: 10.1093/infdis/156.1.225. [DOI] [PubMed] [Google Scholar]
  16. Keith B. R., Maurer L., Spears P. A., Orndorff P. E. Receptor-binding function of type 1 pili effects bladder colonization by a clinical isolate of Escherichia coli. Infect Immun. 1986 Sep;53(3):693–696. doi: 10.1128/iai.53.3.693-696.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Korhonen T. K., Leffler H., Svanborg Edén C. Binding specificity of piliated strains of Escherichia coli and Salmonella typhimurium to epithelial cells, saccharomyces cerevisiae cells, and erythrocytes. Infect Immun. 1981 May;32(2):796–804. doi: 10.1128/iai.32.2.796-804.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Korhonen T. K., Parkkinen J., Hacker J., Finne J., Pere A., Rhen M., Holthöfer H. Binding of Escherichia coli S fimbriae to human kidney epithelium. Infect Immun. 1986 Nov;54(2):322–327. doi: 10.1128/iai.54.2.322-327.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Korhonen T. K., Valtonen M. V., Parkkinen J., Väisänen-Rhen V., Finne J., Orskov F., Orskov I., Svenson S. B., Mäkelä P. H. Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun. 1985 May;48(2):486–491. doi: 10.1128/iai.48.2.486-491.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Korhonen T. K., Virkola R., Holthöfer H. Localization of binding sites for purified Escherichia coli P fimbriae in the human kidney. Infect Immun. 1986 Nov;54(2):328–332. doi: 10.1128/iai.54.2.328-332.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Korhonen T. K., Väisänen-Rhen V., Rhen M., Pere A., Parkkinen J., Finne J. Escherichia coli fimbriae recognizing sialyl galactosides. J Bacteriol. 1984 Aug;159(2):762–766. doi: 10.1128/jb.159.2.762-766.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Källenius G., Möllby R., Svenson S. B., Winberg J., Hultberg H. Identification of a carbohydrate receptor recognized by uropathogenic Escherichia coli. Infection. 1980;8 (Suppl 3):288–293. doi: 10.1007/BF01639597. [DOI] [PubMed] [Google Scholar]
  23. Leffler H., Svanborg-Edén C. Glycolipid receptors for uropathogenic Escherichia coli on human erythrocytes and uroepithelial cells. Infect Immun. 1981 Dec;34(3):920–929. doi: 10.1128/iai.34.3.920-929.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lindberg F. P., Lund B., Normark S. Genes of pyelonephritogenic E. coli required for digalactoside-specific agglutination of human cells. EMBO J. 1984 May;3(5):1167–1173. doi: 10.1002/j.1460-2075.1984.tb01946.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nowicki B., Holthöfer H., Saraneva T., Rhen M., Väisänen-Rhen V., Korhonen T. K. Location of adhesion sites for P-fimbriated and for 075X-positive Escherichia coli in the human kidney. Microb Pathog. 1986 Apr;1(2):169–180. doi: 10.1016/0882-4010(86)90019-7. [DOI] [PubMed] [Google Scholar]
  26. Nowicki B., Rhen M., Väisänen-Rhen V., Pere A., Korhonen T. K. Immunofluorescence study of fimbrial phase variation in Escherichia coli KS71. J Bacteriol. 1984 Nov;160(2):691–695. doi: 10.1128/jb.160.2.691-695.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Nowicki B., Vuopio-Varkila J., Viljanen P., Korhonen T. K., Mäkelä P. H. Fimbrial phase variation and systemic E. coli infection studied in the mouse peritonitis model. Microb Pathog. 1986 Aug;1(4):335–347. doi: 10.1016/0882-4010(86)90066-5. [DOI] [PubMed] [Google Scholar]
  28. O'Hanley P., Lark D., Falkow S., Schoolnik G. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. J Clin Invest. 1985 Feb;75(2):347–360. doi: 10.1172/JCI111707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Old D. C. Inhibition of the interaction between fimbrial haemagglutinins and erythrocytes by D-mannose and other carbohydrates. J Gen Microbiol. 1972 Jun;71(1):149–157. doi: 10.1099/00221287-71-1-149. [DOI] [PubMed] [Google Scholar]
  30. Orskov I., Orskov F., Birch-Andersen A. Comparison of Escherichia coli fimbrial antigen F7 with type 1 fimbriae. Infect Immun. 1980 Feb;27(2):657–666. doi: 10.1128/iai.27.2.657-666.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Orskov I., Orskov F. Serology of Escherichia coli fimbriae. Prog Allergy. 1983;33:80–105. [PubMed] [Google Scholar]
  32. PORTER R. R. The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. Biochem J. 1959 Sep;73:119–126. doi: 10.1042/bj0730119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Parkkinen J., Finne J. Isolation and structural characterization of five major sialyloligosaccharides and a sialylglycopeptide from normal human urine. Eur J Biochem. 1983 Nov 2;136(2):355–361. doi: 10.1111/j.1432-1033.1983.tb07749.x. [DOI] [PubMed] [Google Scholar]
  34. Parkkinen J., Korhonen T. K., Pere A., Hacker J., Soinila S. Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J Clin Invest. 1988 Mar;81(3):860–865. doi: 10.1172/JCI113395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pere A., Leinonen M., Väisänen-Rhen V., Rhen M., Korhonen T. K. Occurrence of type-1C fimbriae on Escherichia coli strains isolated from human extraintestinal infections. J Gen Microbiol. 1985 Jul;131(7):1705–1711. doi: 10.1099/00221287-131-7-1705. [DOI] [PubMed] [Google Scholar]
  36. Pere A., Nowicki B., Saxén H., Siitonen A., Korhonen T. K. Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. J Infect Dis. 1987 Oct;156(4):567–574. doi: 10.1093/infdis/156.4.567. [DOI] [PubMed] [Google Scholar]
  37. Pere A., Väisänen-Rhen V., Rhen M., Tenhunen J., Korhonen T. K. Analysis of P fimbriae on Escherichia coli O2, O4, and O6 strains by immunoprecipitation. Infect Immun. 1986 Feb;51(2):618–625. doi: 10.1128/iai.51.2.618-625.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rhen M., Klemm P., Korhonen T. K. Identification of two new hemagglutinins of Escherichia coli, N-acetyl-D-glucosamine-specific fimbriae and a blood group M-specific agglutinin, by cloning the corresponding genes in Escherichia coli K-12. J Bacteriol. 1986 Dec;168(3):1234–1242. doi: 10.1128/jb.168.3.1234-1242.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Roberts J. A., Hardaway K., Kaack B., Fussell E. N., Baskin G. Prevention of pyelonephritis by immunization with P-fimbriae. J Urol. 1984 Mar;131(3):602–607. doi: 10.1016/s0022-5347(17)50513-3. [DOI] [PubMed] [Google Scholar]
  40. Silverblatt F. J., Dreyer J. S., Schauer S. Effect of pili on susceptibility of Escherichia coli to phagocytosis. Infect Immun. 1979 Apr;24(1):218–223. doi: 10.1128/iai.24.1.218-223.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Väisänen-Rhen V., Elo J., Väisänen E., Siitonen A., Orskov I., Orskov F., Svenson S. B., Mäkelä P. H., Korhonen T. K. P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun. 1984 Jan;43(1):149–155. doi: 10.1128/iai.43.1.149-155.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Väisänen-Rhen V. Fimbria-like hemagglutinin of Escherichia coli O75 strains. Infect Immun. 1984 Nov;46(2):401–407. doi: 10.1128/iai.46.2.401-407.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ward G. K., Stewart S. S., Price G. B., Mackillop W. J. Cellular heterogeneity in normal human urothelium: quantitative studies of lectin binding. Histochem J. 1987 Jun-Jul;19(6-7):337–344. doi: 10.1007/BF01680450. [DOI] [PubMed] [Google Scholar]
  44. Westerlund B., Merenmies J., Rauvala H., Miettinen A., Järvinen A. K., Virkola R., Holthöfer H., Korhonen T. K. The O75X adhesin of uropathogenic Escherichia coli: receptor-active domains in the canine urinary tract and in-vitro interaction with laminin. Microb Pathog. 1987 Aug;3(2):117–127. doi: 10.1016/0882-4010(87)90070-2. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES